Inventor

CASELLAS PIERRE

FR48 patents

⚠️ This page may combine multiple inventors who share the name “CASELLAS PIERRE”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

CASELLAS PIERRE

SANOFI AVENTIS

2-acylamino-4-phenylthiazole derivatives, preparation thereof and therapeutic application thereof

2-acylamino-4-phenylthiazole derivatives, preparation thereof and therapeutic application thereof

Use of pyridoindolone derivatives for preparing anticancer medicines

Tetrahydropyridyl-alkyl-heterocycles, method for preparing the same and pharmaceutical compositions containing the same

Derivatives of pyrido[2,3-d]pyrimidine, the preparation thereof, and the therapeutic application of the same

Derivatives of pyrido[2,3-d]pyrimidine, the preparation thereof, and the therapeutic application of the same

Pyrido-pyrimidine derivatives, preparation thereof, and therapeutic use thereof

Pyrido-pyrimidine derivatives, preparation thereof, and therapeutic use thereof

Pyridoindolone derivatives substituted in the 3-position by a phenyl, their preparation and their application in therapeutics

2-amido-4-phenylthiazole derivatives, the preparation and the therapeutic use thereof

Pyridoindolone derivatives substituted in the 3-position by a phenyl, their preparation and their application in therapeutics

Aralkyltetrahydropyridines, their preparation and pharmaceutical compositions containing them

Pyridoindolone derivatives substituted in the 3-position by a heterocyclic group, their preparation and their application in therapeutics

Pharmaceutical combinations based on pyridoindolone derivatives and anticancer agents

Pyridoindolone derivatives substituted in the 3-position by a heterocyclic group, their preparation and their application in therapeutics

Aralkyl-tetrahydro-pyridines, their preparation and pharmaceutical compositions containing same

Use of pyridoindolone derivatives for the preparation of medicinal products

Nitrogenous tetrahydropyridyl-alkyl-heterocycles with TNF activity

Pyridopyrimidone derivatives, preparation thereof, therapeutic use thereof

Phenyl- and pyridylpiperidines with TNF activity

2-Carbamide-4-phenylthiazole derivatives, preparation thereof and therapeutic use thereof

6-substituted pyridoindolone derivatives, production and therapeutic use thereof

2-carbamide-4-phenylthiazole derivatives, preparation thereof and therapeutic use thereof

SANOFI SA

Pyrazole derivatives, method of preparing them and pharmaceutical compositions in which they are present

Pyrazole-3-carboxamide derivatives, process for their preparation and pharmaceutical compositions in which they are present

CB2 Receptor agonist compounds

3-pyrazolecarboxamide derivatives having cannabinoid receptor affinity

Immunotoxins, process for their preparation and pharmaceutical compositions in which they are present

Pharmaceutical composition comprising a combination of at least one immunotoxin and at least one mannose-containing polymer

Anti-cancer drugs for the treatment of leukaemias I, constituted by the chain A of ricin and a specific monoclanal antibody

Benzene derivatives, their preparation and pharmaceutical compositions in which they are present

Ribosome-inactivating glycoproteins, modified by oxidation of their osidic units and formation of a schiff&#39;s base and in-vivo prolonged action immunotoxins containing such a glycoprotein

Ribosome-inactivating glycoproteins, modified by oxidation of their osidic units and formation of a schiff&#39;s base and in-vivo prolonged action immunotoxins containing such a glycoprotein

Ribosome-inactivating glycoproteins, modified by oxidation of their osidic units and reduction, and in vivo prolonged-action immunotoxins containing such a glycoprotein

Inhibitor of protein synthesis, process for its isolation, its use and pharmaceutical compositions in which it is present

Process for the potentiation of immunotoxins

Benzene derivatives, their preparation and pharmaceutical compositions in which they are present

Ribosome-inactivating glycoproteins, modified by oxidation of their osidic units and reduction, and in vivo prolonged-action immunotoxins containing such a glycoprotein

Modified trichokirin and their preparation for use in conjugates as inhibitors of protein synthesis

SANOFI SYNTHELABO

Use of a substance binding with the peripheral benzodiazepin receptor for treating skin stress

Use of central cannabinoid receptor antagonist for preparing medicines

Benzene derivatives, preparation method and pharmaceutical compositions containing same

Use of tetrahydropyridine derivatives to prepare medicines for treating diseases causing demyelination

Tetrahydropyridines, preparation method and pharmaceutical compositions containing same

SANOFI SYNTELABO

Phenyl- and pyridyl-tetrahydro-pyridines having TNF inhibiting activity

BOURRIE BERNARD

Therapeutic use for treating of leukemia

CASELLAS PIERRE

Slimming cosmetic composition containing a substance inducing the production of IL-6

MUNEAUX YVETTE

6-heteroarylpyridoindolone derivatives, their preparation and therapeutic use thereof

Ribosome-inactivating glycoproteins, modified by oxidation of their osidic units and formation of a schiff's base and in-vivo prolonged action immunotoxins containing such a glycoprotein

Ribosome-inactivating glycoproteins, modified by oxidation of their osidic units and formation of a schiff's base and in-vivo prolonged action immunotoxins containing such a glycoprotein